Buying as well.
I had a thought recently that the recent sell offs might be partly down due to Msb having missed the primary endpoints in 3 trials right after.
Cynata’s cap raising was 11th December which was just before the Msb chf and ards announcements. So might have shaken the belief of some investors who took part in the CR as well as existing ones.
Probably us getting some new positive clinical data would greatly help in that regard.
Anyway just some random musings.
Did you HODL?, page-4
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $58.84K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33236 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 163350 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |